Literature DB >> 21150433

Mast cell CRAC channel as a novel therapeutic target in allergy.

Joseph L Di Capite1, Grant J Bates, Anant B Parekh.   

Abstract

PURPOSE OF REVIEW: This review describes recent advances in our understanding of a major Ca-entry pathway, the Ca release-activated Ca (CRAC) channel, that is central to mast cell activation. RECENT
FINDINGS: Animals in which the genes encoding the CRAC channel have been deleted have severely compromised mast cell function and reduced allergic responses. These functional consequences reflect the ability of CRAC channels to activate a range of spatially and temporally distinct responses in mast cells, which contribute to both rapid and slow phases of an allergic response. In addition, the cells can sustain their own activation through positive feedback cycles that involve CRAC channels. Drugs that inhibit CRAC channels are proving effective in treatment of allergic responses both in vitro and in animal models of asthma.
SUMMARY: CRAC channels comprise a new therapeutic target for combating allergies including asthma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21150433     DOI: 10.1097/ACI.0b013e32834232b0

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  22 in total

1.  Signaling pathways activated by a protease allergen in basophils.

Authors:  Rachel K Rosenstein; Jelena S Bezbradica; Shuang Yu; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

2.  17β-Estradiol inhibits phosphorylation of stromal interaction molecule 1 (STIM1) protein: implication for store-operated calcium entry and chronic lung diseases.

Authors:  John T Sheridan; Rodney C Gilmore; Michael J Watson; Christopher B Archer; Robert Tarran
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

3.  Structure-activity relationship study and discovery of indazole 3-carboxamides as calcium-release activated calcium channel blockers.

Authors:  Sha Bai; Masazumi Nagai; Steffi K Koerner; Aristidis Veves; Lijun Sun
Journal:  Bioorg Med Chem Lett       Date:  2016-12-27       Impact factor: 2.823

Review 4.  Regulation of mast cell responses in health and disease.

Authors:  Alasdair M Gilfillan; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

5.  The C- and N-terminal STIM1 binding sites on Orai1 are required for both trapping and gating CRAC channels.

Authors:  Beth A McNally; Agila Somasundaram; Amit Jairaman; Megumi Yamashita; Murali Prakriya
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

6.  Knockout of the Trpc1 gene reveals that TRPC1 can promote recovery from anaphylaxis by negatively regulating mast cell TNF-α production.

Authors:  Nevenka Medic; Avanti Desai; Ana Olivera; Joel Abramowitz; Lutz Birnbaumer; Michael A Beaven; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Cell Calcium       Date:  2013-03-13       Impact factor: 6.817

7.  Discovery and structural optimization of 1-phenyl-3-(1-phenylethyl)urea derivatives as novel inhibitors of CRAC channel.

Authors:  Hai-zhen Zhang; Xiao-lan Xu; Hua-yan Chen; Sher Ali; Dan Wang; Jun-wei Yu; Tao Xu; Fa-jun Nan
Journal:  Acta Pharmacol Sin       Date:  2015-08-10       Impact factor: 6.150

8.  Ca2+ release-activated Ca2+ channel blockade as a potential tool in antipancreatitis therapy.

Authors:  Julia V Gerasimenko; Oleksiy Gryshchenko; Pawel E Ferdek; Eloise Stapleton; Tania O G Hébert; Solomiia Bychkova; Shuang Peng; Malcolm Begg; Oleg V Gerasimenko; Ole H Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

Review 9.  Store-operated Orai channels: structure and function.

Authors:  Murali Prakriya
Journal:  Curr Top Membr       Date:  2013       Impact factor: 3.049

Review 10.  Emerging roles of store-operated Ca²⁺ entry through STIM and ORAI proteins in immunity, hemostasis and cancer.

Authors:  Wolfgang Bergmeier; Carl Weidinger; Isabelle Zee; Stefan Feske
Journal:  Channels (Austin)       Date:  2013-03-19       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.